{"id":18838,"date":"2025-03-15T17:59:26","date_gmt":"2025-03-15T16:59:26","guid":{"rendered":"https:\/\/drugprevent.org.uk\/ppp\/?p=18838"},"modified":"2025-05-20T19:12:56","modified_gmt":"2025-05-20T18:12:56","slug":"the-burden-of-unlawful-use-of-opioid-and-associated-epidemiological-characteristics-in-africa-a-scoping-review","status":"publish","type":"post","link":"https:\/\/drugprevent.org.uk\/ppp\/2025\/03\/the-burden-of-unlawful-use-of-opioid-and-associated-epidemiological-characteristics-in-africa-a-scoping-review\/","title":{"rendered":"The burden of unlawful use of opioid and associated epidemiological characteristics in Africa: A scoping review"},"content":{"rendered":"<p>by<strong> Professor Onohuean Hope<\/strong>; Department of Pharmacology and Toxicology, Kampala International University, Uganda, and <strong>Professor Frasia Oosthuizen<\/strong> who holds a BPharm, MSc (Pharmacology) and PhD (Pharmacology) qualifications, all obtained from PU for CHE (now North-West University). Published: March 7, 2025 in the journal <i><b>PLOS One<\/b><\/i>\u00a0(stylized\u00a0<i><b>PLOS ONE<\/b><\/i>, and formerly\u00a0<i>PLoS ONE<\/i>) is a\u00a0peer-reviewed\u00a0open access\u00a0mega journal\u00a0published by the\u00a0Public Library of Science\u00a0(PLOS) since 2006.<\/p>\n<p>Published: March 7, 2025<\/p>\n<p><strong>ABSTRACT<\/strong><\/p>\n<p><strong>Introduction<\/strong><br \/>\nThere is an ongoing global upsurge of opioid misuse, fatal overdose and other related<br \/>\ndisorders, significantly affecting the African continent, due to resource-limited settings and<br \/>\npoor epidemiological surveillance systems. This scoping review maps scientific evidence<br \/>\non epidemiological data on unlawful opioid use to identify knowledge gaps and policy<br \/>\nshortcomings.<\/p>\n<p><strong>Method<\/strong><br \/>\nThe databases (PubMed, Scopus, Web of Sciences) and references were searched<br \/>\nguided by Population, Concept, and Context (PCC) and PRISMA-ScR. The extracted<br \/>\ncharacteristics examined were author\/year, African country, epidemiological distribution,<br \/>\nage group (year), gender, study design and setting, common opioid\/s abused, sources of<br \/>\ndrugs, reasons for misuse, summary outcomes and future engagement.<\/p>\n<p><strong>Results<\/strong><br \/>\nA population of 55132 participated in the included studies of 68 articles, with the<br \/>\nlargest sample size of 17260 (31.31%) in a study done in South Africa, 11281(20.46%)<br \/>\nin a study from Egypt and 4068 (7.38%) in a study from Ethiopia. The gender of the<br \/>\nparticipants was indicated in 65(95.59%) papers. The mean and median age reported<br \/>\nin 57(83.82%) papers were 15.9-38, and 22-31years. The majority of study-designs<br \/>\nwere cross-sectional, 44(64.71%), and the most used opioids were heroin, 14articles<br \/>\n(20.59%), tramadol, 8articles (11.76%), and tramadol &amp; heroin, 6 articles (8.82%)<br \/>\narticles. Study-settings included urban community 15(22.06%), hospital 15(22.06%),<br \/>\nuniversity students 11(16.18%), and secondary school learners 6(8.82%). The highest<br \/>\nepidemiological distributions were recorded in the South African study, 19615(35.60%),<br \/>\nEgyptian study, 14627(26.54%), and Nigerian study 5895(10.70%). Nine (13.24%)<br \/>\npapers reported major opioid sources as black market, friends, and drug dealers. To<br \/>\nrelieve stress, physical pain and premature ejaculation, improve mood and sleep-related<br \/>\nPLOS ONE | https:\/\/doi.org\/10.1371\/journal.pone.0317036 March 7, 2025 2 \/ 24<br \/>\nPLOS ONE The burden of unlawful use of opioid and associated epidemiological characteristics in Africa<br \/>\nproblems and help to continue work, were the major reasons for taking these drugs as<br \/>\nreported in twenty articles (29.41%).<\/p>\n<p><strong>Conclusion<\/strong><br \/>\nThe findings of this scoping review show significant knowledge gaps on opioid usage in<br \/>\nthe African continent. The epidemiological distribution of unlawful use of opioids among<br \/>\nyoung adults, drivers, and manual labourers in both genders is evident in the findings.<br \/>\nThe reason for use necessity scrutinises the role of social interaction, friends and family<br \/>\ninfluence on illicit opiate use. Therefore, there is a need for regular epidemiological<br \/>\nsurveillance and investigations into multilevel, value-based, comprehensive, and strategic<br \/>\nlong-term intervention plans to curb the opioid problem in the region.<\/p>\n<p><span style=\"font-size: 14pt;\"><strong>To access the full document, please click on the link below:<\/strong><\/span><\/p>\n<p><span style=\"font-size: 14pt;\"><strong>\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0<a href=\"https:\/\/doi.org\/10.1371\/journal.pone.0317036\">https:\/\/doi.org\/10.1371\/journal.pone.0317036<\/a><\/strong><\/span><\/p>\n","protected":false},"excerpt":{"rendered":"<p>by Professor Onohuean Hope; Department of Pharmacology and Toxicology, Kampala International University, Uganda, and Professor Frasia Oosthuizen who holds a BPharm, MSc (Pharmacology) and PhD (Pharmacology) qualifications, all obtained from PU for CHE (now North-West University). Published: March 7, 2025 in the journal PLOS One\u00a0(stylized\u00a0PLOS ONE, and formerly\u00a0PLoS ONE) is a\u00a0peer-reviewed\u00a0open access\u00a0mega journal\u00a0published by the\u00a0Public [&hellip;]<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[73,68,135,20],"tags":[],"class_list":["post-18838","post","type-post","status-publish","format-standard","hentry","category-addiction","category-drug-use-various-effects","category-opioids","category-others"],"_links":{"self":[{"href":"https:\/\/drugprevent.org.uk\/ppp\/wp-json\/wp\/v2\/posts\/18838","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/drugprevent.org.uk\/ppp\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/drugprevent.org.uk\/ppp\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/drugprevent.org.uk\/ppp\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/drugprevent.org.uk\/ppp\/wp-json\/wp\/v2\/comments?post=18838"}],"version-history":[{"count":0,"href":"https:\/\/drugprevent.org.uk\/ppp\/wp-json\/wp\/v2\/posts\/18838\/revisions"}],"wp:attachment":[{"href":"https:\/\/drugprevent.org.uk\/ppp\/wp-json\/wp\/v2\/media?parent=18838"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/drugprevent.org.uk\/ppp\/wp-json\/wp\/v2\/categories?post=18838"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/drugprevent.org.uk\/ppp\/wp-json\/wp\/v2\/tags?post=18838"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}